Compare Merck & Co., Inc. (MRK) vs STMicroelectronics NV (STM) Price & Performance

Merck & Co., Inc.Trade

STMicroelectronics NVTrade

Price performance (Past 24H)

Key statistics

Merck & Co., Inc. vs STMicroelectronics NV — how do they compare? Merck & Co., Inc. trades at $130.24 (market cap $321.77B), while STMicroelectronics NV trades at $56.02 (market cap $49.21B). The key difference: Merck & Co., Inc. is far larger — about 6.5× STMicroelectronics NV's market cap, and Merck & Co., Inc. pays the higher dividend (2.61%). Which is the better fit depends on your goals.

	MRK	STM
Market Cap	$321.77B	$49.21B
Sector	Health	Financials
52-Week High	$131.84	$79.91
52-Week Low	$77.60	$21.20
Enterprise Value	$368.53B	$47.21B
Dividend Yield	2.61%	0.65%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Merck & Co., Inc.

Merck (MRK) trades at $130.9, up 1.81% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $140.36. Recent earnings beats and a 72.97% gross margin highlight strong profitability, while the acquisition of Terns Pharmaceuticals aims to bolster its oncology pipeline. The stock faces headwinds from a high P/E ratio of 104.34 and fluctuating cash flows.

The outlook is positive with robust fundamentals and strategic M&A, but valuation concerns and competitive pressures in pharma pose risks. Upside is likely if earnings growth continues, though investors should monitor debt levels and integration of acquisitions.

STMicroelectronics NV

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRK

Bio-Techne reports flat FY2026 revenue, EPS rise, and confirms $11.3B acquisition by Merck KGaA.PRNewsWire · 5 hours agoBullish Trump orders splitting MMR vaccine into three shots despite no scientific support and expert criticism.CNBC · 23 hours agoBearish View details →

STM

ON Semiconductor sees 34% upside as AI data center revenue and EV power tech boost growth outlook24/7 Wall Street · 2 days agoBullish TSMC's July revenue jumps 44.7% YoY, signaling strong AI chip demand and boosting semiconductor stocks.CNBC · 2 days agoBullish View details →

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

About STMicroelectronics NV

A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.